Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-24

Clinical Trial Update: A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

View source ↗

Summary

A completed clinical trial evaluating 24 months of Minirin Melt for nocturia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minirin Melt (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Status: COMPLETED